About
Edity develops an AI-powered platform that engineers therapeutic proteins for targeted intracellular delivery using immune cells, aiming to treat diseases including solid tumors by reprogramming the tumor microenvironment and enhancing cell therapies such as CAR T.
Explore Edity's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.